
Over 130 health care facilities get national quality certification within 18 months in Chattisgarh's Bastar
Over 130 institutions based in the region across the seven Maoist-affected districts of Bastar got National Quality Certification during the last one and a half years.
From national-level quality certifications to recruitment of specialists, bolstering medical staffing and direct health assistance, the numbers hint at development reaching even the remotest corners of the insurgency-hit belt.
Between January 1, 2024, to June 16, 2025, as many as 130 health institutions in the Bastar division have been certified under the National Quality Assurance Standards (NQAS). These include one district hospital, 16 Primary Health Centres (PHCs), and 113 Sub-Health Centres (SHCs).
What remains noteworthy is 14 institutions in the highly sensitive districts of Kanker, Bijapur, Sukma, and Dantewada have achieved certification. An additional 65 facilities are currently undergoing the certification process.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
2 hours ago
- Time of India
Heart attack in Maoist zone, Lloyds MD airlifts ailing cop
Nagpur: A remote Maoist-hit outpost in Maharashtra's Gadchiroli. A 37-year-old cop clutching his chest. A helicopter thunders into the skies — at the controls, a steel company's managing director. Tired of too many ads? go ad free now M Prabhakaran, MD of Lloyds Metals and Energy Ltd (LMEL), personally flew a helicopter to evacuate Naik Rahul Gaikwad of SRPF Group-II from Gadchiroli's Hedri police station after the constable suffered a heart attack on Aug 2. Gaikwad had reached Lloyds Kali Ammal Memorial Hospital around noon, complaining of severe chest pain. An ECG confirmed an anterior lateral wall myocardial infarction — a critical, life-threatening cardiac event. He was moved to ICU, given anti-platelets and low molecular weight heparin, but needed advanced cardiac care fast. Time was slipping. Police reached out to LMEL's top brass. Prabhakaran, a licenced pilot with over 10 years of flying experience, was inspecting the company's Surjagarh Iron Ore mines when he got the call. He dropped everything, offered LMEL's helicopter for evacuation, and personally took the controls. At 2.45pm, the helicopter lifted off from Hedri's armed outpost helipad with Gaikwad and a nursing team on board to monitor vitals. By 3.40pm, the helicopter landed at Nagpur airport, where an ambulance from Orange City Hospital was on standby. Gaikwad was rushed in. Doctors found a single artery blockage and placed a stent on Aug 4. He was discharged the following night. From creating a steel hub in a conflict-prone region to building critical healthcare access, LMEL's efforts — and Prabhakaran's personal act — are being hailed as a model of hands-on corporate social responsibility.


Time of India
3 hours ago
- Time of India
Under NQAS, more than 130 health institutions in Bastar get certification
Raipur: Over 130 health institutions across Chhattisgarh's Bastar division have been certified under the National Quality Assurance Standards (NQAS) between Jan 2024 and June 2025. The certified facilities include one district hospital, 16 primary health centres (PHCs), and 113 sub-health centres (SHCs), with 14 institutions located in the sensitive districts of Kanker, Bijapur, Sukma, and Dantewada, getting certified. State has ramped up enrolment under 'Niyad Nellanar' scheme, accelerating the issuance of Ayushman cards to ensure health access for economically weaker sections. In the past year alone, over 36,000 Ayushman cards have been created, covering 52.6% of eligible population, an official statement from govt stated. More than Rs 8.22 crore in health assistance has been extended to 6,816 beneficiaries across the division, it said. Speaking on the progress, CM Vishnu Deo Sai said, "This transformation wouldn't be possible without the active involvement of mitanins, health workers, and the health department staff. Bastar has always been a priority for our govt. We are committed to improving it further." To strengthen health delivery, the govt has made over 450 staff appointments in the division over the past 18 months including 33 medical specialists, 117 medical officers, and a dental surgeon, along with 75 state-level and 307 district-level recruits. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like For all your EV needs ScottishPower Learn More Undo An additional 291 vacancies are in the process of being filled. Health minister Shyam Bihari Jaiswal, who is undertaking a three-day tour of Bastar from Aug 5 to 7, reiterated the state's goal of ensuring equal access to quality healthcare across all regions. During his visit, Jaiswal will review major hospitals, hold meetings with autonomous health committees, inspect progress on the malaria-free Bastar campaign, and assess services in remote villages of Bijapur and Sukma. Highlighting the govt's resolve, Minister Jaiswal noted, "Even in areas previously considered unreachable due to insurgency, our teams are delivering services door to door. Under the NQAS program, Bastar's health institutions are becoming national benchmarks." The progress in Bastar, once symbolic of underdevelopment—now serves as a model of focused governance and inclusive growth, demonstrating how dedicated leadership can bridge even the toughest healthcare gaps.


Time of India
17 hours ago
- Time of India
WHO calls for research scale-up towards ending TB in South-East Asia region
New Delhi: The WHO on Tuesday called for urgent scale-up of research, innovation and collaboration to accelerate momentum towards ending tuberculosis in the South-East Asia region, which continues to bear nearly half of the global TB burden , accounting for the highest share of cases and deaths worldwide. Experts, national TB programme managers and researchers along with partners and members of civil society began a three-day virtual workshop organised by the World Health Organization (WHO) for advancing research and innovation to accelerate momentum towards ending TB in the WHO South-East Asia region. "In our Region alone, nearly 5 million people developed TB and close to 600,000 died from the disease in 2023," said Dr Catharina Boehme, Officer-in-Charge, WHO South-East Asia Region. Calling for urgent action, she said that achieving the ambitious targets in the WHO End TB Strategy requires collaboration to accelerate research and innovation. It requires the adoption and use of new tools, technologies and drugs. Ensuring timely and equitable access to these innovations remains critical to achieving impacts at scale, leaving no one behind, Boehme said. While the region recorded a significant increase in TB case notifications in 2023, signalling recovery after COVID-19-related setbacks, progress remains insufficient to meet the End TB Strategy targets aligned with the sustainable development goals that call for a 90 per cent reduction in TB deaths and an 80 per cent reduction in incidence by 2030 compared to 2015 levels. Post-COVID-19 pandemic, TB once again reemerged as the world's leading cause of death from a single infectious agent, the WHO said in a statement. It places a disproportionate burden on the poorest and most vulnerable, further exacerbating inequalities. In the South-East Asia region, 30 per cent to 80 per cent of the TB-affected households experience catastrophic costs, underscoring the need for equitable, people-centred approaches and strengthening social protection for the affected, the statement said. Despite these challenges, the WHO South-East Asia region made notable progress. In 2023, 3.8 million new and relapse TB cases were notified, with an 89 per cent treatment success rate for those who began treatment in 2022. Missed cases dropped to 22 per cent in 2023, down from 44 per cent in 2020, the statement said. Backed by strong political commitment, countries in the region are increasingly leveraging new approaches such as artificial intelligence for case detection, computer-aided diagnostics, digital adherence tools and direct benefit transfers for patients, streamlining the social support process. At the same time, several countries are undertaking important research, including epidemiological research to assess the disease burden, the statement said. Bangladesh recently completed a patient cost survey, while findings from India's RATIONS study on the impact of nutrition on TB outcomes and incidence of the disease have contributed to the global guidance. Social and community-based innovations are also playing a vital role. Nepal's TB-Free Pallika initiative and multisectoral coordination mechanisms in Myanmar are helping reach vulnerable populations with person-centred care. A review by the WHO South-East Asia found that member states published over 3,000 TB-related research articles in the past six years, with 60 per cent being original research. However, uptake of research outcomes remains uneven due to knowledge gaps and limited platforms for knowledge exchange and collaborative use, the statement said. "Our progress is uneven. Research and innovation capacity is varied across the Region, and the results of these efforts are often siloed and unavailable for collaborative use. The rise in drug-resistant forms of TB remains very concerning," said Dr Boehme. The key areas of focus during the virtual consultation include strengthening of South-South collaboration, vaccine preparedness, digital tools for patient care and adherence and efforts to overcome vaccine hesitancy. Participants will also discuss aligning regulatory processes, promoting data sharing and improving platforms for knowledge exchange. A significant emphasis is being placed on identifying operational implementation research priorities, especially in relation to social determinants such as undernutrition and climate change, which influence TB incidence and outcomes. "Several ongoing innovations are attempting to reach out to marginalized and vulnerable groups through active case finding and providing affected families socio-economic support to mitigate catastrophic costs", said Dr Boehme. Highlighting the importance of equity, she added, "It is incumbent to ensure equitable access to the benefits of research and innovation, including vaccines, medicines and diagnostics."